Can you get medical cannabis for anxiety in the UK?

Anxiety disorders are among the more common reasons for private medical cannabis prescriptions in the UK, and among the most carefully assessed. The reason is straightforward: the same compound that reduces anxiety in some people reliably increases it in others, and there is no test that tells you in advance which you are.

Is anxiety treated with medical cannabis in the UK?

Anxiety disorders are assessed by private specialists and are among the more frequent reasons for private prescriptions in the UK. Nothing is licensed for anxiety, NICE does not recommend cannabis-based medicines for it, and this is not an NHS treatment.

UK guidance for generalised anxiety disorder (NICE CG113) sets out a stepped approach: education and active monitoring, then low-intensity psychological interventions, then cognitive behavioural therapy or an SSRI, then specialist referral. These have substantially better evidence than anything on this page, and a specialist will expect to see that they have been genuinely tried — not merely offered and declined, and not a six-week wait that never turned into an appointment.

Assessment for anxiety is more searching than for a pain condition, and that is appropriate rather than obstructive. A clinic that prescribes for anxiety after a brief conversation is not doing the assessment properly.

What the evidence actually shows

The controlled evidence in anxiety concerns single doses of cannabidiol in experimental situations. It is interesting pharmacology. It is not evidence that long-term treatment with a THC-containing product helps an anxiety disorder.

The most-cited study gave 24 people with untreated social anxiety disorder a single 600 mg dose of cannabidiol or placebo before a simulated public speaking test. Anxiety, cognitive impairment and discomfort during the speech were significantly reduced in the cannabidiol group, whose responses came to resemble those of healthy controls. That is a real finding — about one dose, of purified CBD, in one artificial stressor, in 24 people.

Reviews of cannabinoids for mental health conditions have generally concluded that there is insufficient evidence to support their use for anxiety disorders, and have noted the risk of harm. UK registry data reports improvements in anxiety scores in patients prescribed for various conditions, with the standard observational caveat. THC specifically has a well-documented biphasic effect: lower doses can be anxiolytic, higher doses anxiogenic, and the crossover point varies between people.

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For anxiety they will typically look at:

• Which anxiety disorder you have, and whether it has been diagnosed rather than self-identified
• Whether you have had cognitive behavioural therapy or another NICE-recommended psychological therapy
• Which medicines you have tried — SSRIs, SNRIs, pregabalin — and what happened
• Any personal or family history of psychosis, schizophrenia or bipolar disorder
• Your current alcohol and drug use, including any existing cannabis use
• Whether anxiety is the primary problem or secondary to pain, trauma or another condition being treated

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

THC can cause anxiety, panic and paranoia — the very symptoms being treated. This is not a rare idiosyncratic reaction; it is a well-described dose-related effect, and it is the central risk here.

A personal or family history of psychosis, schizophrenia or bipolar disorder weighs heavily against THC-containing treatment, because regular THC use is associated with an increased risk of psychotic illness in susceptible people. Regular use can also lead to dependence, and stopping can produce irritability, poor sleep and increased anxiety — which is easily mistaken for the underlying condition returning. If you are already using cannabis for anxiety, say so at assessment: it changes the clinical picture and it is not a mark against you.

If your anxiety is severe, or you are having thoughts of harming yourself, contact your GP or NHS 111, or call 999 in an emergency. Samaritans can be reached free on 116 123 at any time.

How medical cannabis is thought to help

Any account of how cannabis-based medicines might act on anxiety has to be tentative, because the mechanisms are only partly understood and the controlled evidence is thin. What can be said is general, and it is worth understanding before you place any weight on it.

The body has its own endocannabinoid system — a network of receptors and signalling molecules involved in regulating mood, the stress response, sleep, appetite and the perception of pain. THC and CBD interact with this system in different ways. THC acts directly on cannabinoid receptors and is responsible for the intoxicating effects; CBD works more indirectly and is not intoxicating. In anxiety this difference is not academic: it is precisely why THC can settle symptoms at a lower exposure and provoke them at a higher one, while CBD has been studied for a calming effect without the same biphasic swing. If you want the underlying biology rather than the condition-specific picture, the guides on the endocannabinoid system and THC and CBD set it out in plain terms.

None of this amounts to a proven mechanism for treating an anxiety disorder. It explains why the compounds are studied, not that they reliably work.

What treatment involves in practice

If a specialist does decide a monitored trial is justified for you, treatment follows the same cautious pattern used across this field: start low, increase slowly, and review often.

Unlicensed cannabis-based products are prescribed on a named-patient basis, which places responsibility for the decision and for informed consent with the specialist rather than with a manufacturer's licence. Treatment usually begins at a low dose and is titrated upwards gradually, so that any benefit and any side effects can be judged against small, deliberate changes rather than a single leap — an approach that matters more in anxiety than almost anywhere else, given how sharply the effect of THC can change with dose. Most prescriptions take the form of an oil or capsule taken by mouth, or dried flower for vaporising; the two behave differently in how quickly they act and how long they last, which is covered in how cannabis-based medicines are taken and how long they take to work.

Follow-up reviews are not a formality. They are where the specialist checks whether the treatment is genuinely helping your anxiety, whether side effects are tolerable, and whether the dose needs adjusting — or whether it should be stopped because it is not earning its place. How a dose is set and changed is explained in how a dose is decided and adjusted, the range of unwanted effects in side effects of cannabis-based medicines, and the practical business of driving, work and keeping your GP informed in the guides on driving, drug testing and work and telling your GP.

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If anxiety is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026